Evidence map›Paper›PMID 41226496›Full record

ArticleInternational journal of molecular sciences2025

Pleiotropic Effects of Polymorphisms in the

Antonio Mateus Oliveira, Luciana Fiuza, Camylla Figueiredo, Caroline Guarda, Rayra Santiago, Sètondji Yahouédéhou, Suéllen Carvalho, Ana Paula Pacheco, Isa Lyra, Elisângela Vitória Adorno and 2 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Antonio Mateus OliveiraLaboratório de Investigação em Saúde Global e Doenças Negligenciadas, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz-Fiocruz Bahia, Salvador 40296-710, Bahia, Brazil.ORCID 0000-0002-4408-2680
Luciana FiuzaLaboratório de Investigação em Saúde Global e Doenças Negligenciadas, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz-Fiocruz Bahia, Salvador 40296-710, Bahia, Brazil.
Camylla FigueiredoLaboratório de Investigação em Saúde Global e Doenças Negligenciadas, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz-Fiocruz Bahia, Salvador 40296-710, Bahia, Brazil.
Caroline GuardaLaboratório de Investigação em Saúde Global e Doenças Negligenciadas, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz-Fiocruz Bahia, Salvador 40296-710, Bahia, Brazil.
Rayra SantiagoLaboratório de Investigação em Saúde Global e Doenças Negligenciadas, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz-Fiocruz Bahia, Salvador 40296-710, Bahia, Brazil.
Sètondji YahouédéhouLaboratório de Investigação em Saúde Global e Doenças Negligenciadas, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz-Fiocruz Bahia, Salvador 40296-710, Bahia, Brazil.ORCID 0000-0003-4219-1311
Suéllen CarvalhoLaboratório de Investigação em Saúde Global e Doenças Negligenciadas, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz-Fiocruz Bahia, Salvador 40296-710, Bahia, Brazil.
Ana Paula PachecoLaboratório de Investigação em Saúde Global e Doenças Negligenciadas, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz-Fiocruz Bahia, Salvador 40296-710, Bahia, Brazil.
Isa LyraHospital do Subúrbio, Salvador 40720-460, Bahia, Brazil.
Elisângela Vitória AdornoLaboratório de Pesquisa em Anemias, Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal da Bahia, Salvador 40170-110, Bahia, Brazil.ORCID 0000-0001-9455-890X
Cynara BarbosaLaboratório de Pesquisa em Anemias, Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal da Bahia, Salvador 40170-110, Bahia, Brazil.
Marilda GonçalvesLaboratório de Investigação em Saúde Global e Doenças Negligenciadas, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz-Fiocruz Bahia, Salvador 40296-710, Bahia, Brazil.

Funding

Fundação de Amparo à Pesquisa do Estado da Bahia 005/2019
6 · The paper itself

Abstract

Sickle cell anemia (SCA) is characterized by hematological events that lead to vaso-occlusion and the onset of clinical manifestations. Fetal hemoglobin (HbF) has been shown to positively influence the clinical outcomes of individuals with SCA. Genetic polymorphisms are known to modulate clinical phenotypes by increasing HbF levels, with the

Indexed as

Anemia, Sickle CellGenetic PleiotropyPolymorphism, Single NucleotideAdolescentAdultBiomarkersFemaleFetal HemoglobinGenetic Predisposition to DiseaseGenotypeHumansMaleMiddle AgedRepressor ProteinsYoung AdultBCL11A protein, humanBiomarkersFetal HemoglobinRepressor ProteinsA1ATBCL11A polymorphismfetal hemoglobinHDLsickle cell anemia

Identifiers

PMID41226496
PMCPMC12609289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.